108 related articles for article (PubMed ID: 22569599)
41. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
[TBL] [Abstract][Full Text] [Related]
42. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
43. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.
Limpaiboon T; Khaenam P; Chinnasri P; Soonklang M; Jearanaikoon P; Sripa B; Pairojkul C; Bhudhisawasdi V
Cancer Lett; 2005 Jan; 217(2):213-9. PubMed ID: 15617839
[TBL] [Abstract][Full Text] [Related]
44. Circulating cell-free DNA use for diagnosing cholangiocarcinoma.
Sorscher S
Clin Epigenetics; 2019 May; 11(1):75. PubMed ID: 31088529
[No Abstract] [Full Text] [Related]
45. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
[TBL] [Abstract][Full Text] [Related]
46. TRAIL-R3-related apoptosis: epigenetic and expression analyses in women with ovarian neoplasia.
Braga Lda C; Alvares da Silva Ramos AP; Traiman P; Silva LM; Lopes da Silva-Filho A
Gynecol Oncol; 2012 Aug; 126(2):268-73. PubMed ID: 22555108
[TBL] [Abstract][Full Text] [Related]
47. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting.
Wojdacz TK; Dobrovic A; Algar EM
Hum Mutat; 2008 Oct; 29(10):1255-60. PubMed ID: 18473334
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
[TBL] [Abstract][Full Text] [Related]
49. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
50. Clustering of hypermethylated genes in neuroblastoma.
van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
[TBL] [Abstract][Full Text] [Related]
51. Optimizing methodologies for PCR-based DNA methylation analysis.
Hernández HG; Tse MY; Pang SC; Arboleda H; Forero DA
Biotechniques; 2013 Oct; 55(4):181-97. PubMed ID: 24107250
[TBL] [Abstract][Full Text] [Related]
52. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
Zhou F; Cao X; Liu M; Wang Y; Tao G
Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
[TBL] [Abstract][Full Text] [Related]
53. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
54. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component.
Chen TC; Ng KF; Kuo T
Mod Pathol; 2001 May; 14(5):527-32. PubMed ID: 11353065
[TBL] [Abstract][Full Text] [Related]
55. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
56. Microdevices for detecting locus-specific DNA methylation at CpG resolution.
Koo KM; Wee EJ; Rauf S; Shiddiky MJ; Trau M
Biosens Bioelectron; 2014 Jun; 56():278-85. PubMed ID: 24514080
[TBL] [Abstract][Full Text] [Related]
57. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
58. High-resolution melting analysis of BLU methylation levels in gastric, colorectal, and pancreatic cancers.
Shao Y; Zhang W; Zhang C; Wu Q; Yang H; Zhang J; Guan M; Wan J; Yu B
Cancer Invest; 2010 Jul; 28(6):642-8. PubMed ID: 20394502
[TBL] [Abstract][Full Text] [Related]
59. si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma.
Xiang J; Luo F; Chen Y; Zhu F; Wang J
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):181-9. PubMed ID: 24361215
[TBL] [Abstract][Full Text] [Related]
60. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
Ye F; Zhang SF; Xie X; Lu WG
Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
